Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin.
about
A second-generation anti TB vaccine is long overdueReduced local growth and spread but preserved pathogenicity of a DeltapurC Mycobacterium tuberculosis auxotrophic mutant in gamma interferon receptor-deficient mice after aerosol infection.Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovisNon-replicating Mycobacterium tuberculosis elicits a reduced infectivity profile with corresponding modifications to the cell wall and extracellular matrix.Mycobacterium tuberculosis metabolismThe combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis.Lack of desensitization of the cough reflex in ovalbumin-sensitized rabbits during exercise.Vaccines for bovine tuberculosis: current views and future prospects.Oral vaccination of guinea pigs with a Mycobacterium bovis bacillus Calmette-Guerin vaccine in a lipid matrix protects against aerosol infection with virulent M. bovisA Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG.Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein.MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer.Lipoarabinomannan mannose caps do not affect mycobacterial virulence or the induction of protective immunity in experimental animal models of infection and have minimal impact on in vitro inflammatory responses.
P2860
Q24800887-1A01B77D-A2B9-4E12-8971-30F65543A7B3Q33557025-B27C4A0D-91B7-47F4-8A8C-884C63C6A97EQ34120896-19103F31-4320-4E42-880F-3B9399404906Q35091433-3EBC7B59-E20D-4EBA-BA1E-D2780A731FFBQ35245286-5806C38D-29C7-46C2-9F24-24CBC6814373Q35689134-93B90EE6-5749-4EF5-A3F0-F0F2888ECE86Q36229158-45922DD9-B738-497F-A486-E95185A916ADQ36275666-03E3495D-F840-400B-A7E5-E1B81667CBAEQ36350586-37A7FD32-D733-45B7-BDF2-04C2AA1B9AB6Q36804289-FF38C1F3-67F1-4708-ABA0-4DB8C575F279Q36950010-856CC131-EF5F-441E-9D2B-792A3A9B878AQ37461305-6103A63F-8CC0-43BD-A234-5D37735B643AQ37737313-7C51C557-7689-4395-91C4-932160950616Q38385719-1D9AF2CF-2779-4976-9BB5-EAEA4B405E6FQ43546947-AB33D127-366F-4A5A-BE44-811EAA38833B
P2860
Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Identification of a Mycobacter ...... t sensitization to tuberculin.
@ast
Identification of a Mycobacter ...... t sensitization to tuberculin.
@en
type
label
Identification of a Mycobacter ...... t sensitization to tuberculin.
@ast
Identification of a Mycobacter ...... t sensitization to tuberculin.
@en
prefLabel
Identification of a Mycobacter ...... t sensitization to tuberculin.
@ast
Identification of a Mycobacter ...... t sensitization to tuberculin.
@en
P2093
P2860
P1476
Identification of a Mycobacter ...... t sensitization to tuberculin.
@en
P2093
A Williams
D Gavier-Widén
M A Chambers
R G Hewinson
W R Jacobs
P2860
P304
P356
10.1128/IAI.68.12.7094-7099.2000
P407
P577
2000-12-01T00:00:00Z